AMPK activator 18
Based on 1 Customer Validation
AMPK activator 18 is a potent allosteric activator of AMPK complexes containing the β2 isoform. AMPK activator 18activates α2-containing AMPK α2β2γ1 and α2β2γ3 complexes, with EC50 values of 17.2 and 82.1 nM. AMPK activator 18 stimulates β2-AMPK in cells, and glucose uptake by isolated skeletal muscle. AMPK activator 18 induces acetyl-coenzyme A carboxylase (ACC) and AMPK α-T172 phosphorylation. AMPK activator 18 can be used for the research of type 2 diabetes.
For research use only. We do not sell to patients.
- CAS No.: 1364692-88-5
- Formula: C26H18ClN3O4
- Molecular Weight:471.90
-
Storage:
4°C, stored under nitrogen
* In solvent : -80°C, 6 months; -20°C, 1 month (stored under nitrogen)
All AMPK Isoforms
More
Biological Activity
Description
IC50 & Target
[1]|
AMPK α2β2γ1 17.2 nM (EC50) |
α2β2γ3 82.1 nM (EC50) |
In Vitro
AMPK activator 18 potently and selectively activates α2-containing AMPK complexes, particularly the skeletal muscle-enriched α2β2γ1 and α2β2γ3 complexes, with EC50 values of 17.2 ± 1.6 nM and 82.1 ± 1.3 nM respectively, and its activation is dependent on the β2-D111 residue but not the β2 N-terminal helix[1].
AMPK activator 18 (0.03-10 μM; 1 h) triggers AMPK signaling in differentiated C2C12 myotubes and β2-reconstituted iMEFs via an allosteric mechanism independent of changes to intracellular AMP/ATP ratio or AMPK α-T172 phosphorylation, inducing dose-dependent ACC phosphorylation[1].
AMPK activator 18 (1-2 μM) increases ACC phosphorylation and AMPK α-T172 phosphorylation levels in Epitrochlearis muscles[1].
AMPK activator 18 (10 μM) reduces 2-deoxyglucose (2DG) uptake in soleus and extensor digitorum longus muscles[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:β2-expressing b1/2 dKO iMEFs
-
Concentration:1 μM; 10 μM
-
Incubation Time:1 h
-
Result:Induced a significant increase in ACC phosphorylation without altering AMPK α-T172 phosphorylation in β2-reconstituted iMEFs at 1 μM.
Induced ACC phosphorylation associated with an increase in AMPK α-T172 phosphorylation in β2-reconstituted iMEFs at 10 μM.
Chemical Information
-
CAS No. 1364692-88-5
-
Appearance Solid
-
Molecular Weight 471.90
-
Formula C26H18ClN3O4
-
Color White to off-white
-
SMILES
O=C(O)C1=CC(OC2=NC3=NC(=C(Cl)C=C3N2)C4=CC=C(C=C4)C5=CC=CC=C5O)=CC=C1C
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
4°C, stored under nitrogen
* In solvent : -80°C, 6 months; -20°C, 1 month (stored under nitrogen)
Protocols
-
Kinase activity and phosphorylation assays
Kinase activity assays measure the ability of kinases to transfer phosphate groups from ATP to specific substrates, while phosphorylation assays detect the presence and levels of phosphorylated proteins. Common methods include radiolabeled ATP incorporation (e. g. ,), ADP release detection via bioluminescence (e. g. ,[3]), enzyme-linked immunosorbent assays (ELISA) for phospho-specific epitopes (e. g. ,[6]), and microtiter-based formats for high-throughput screening (e. g. ,[8]). The ADP-Glo assay quantifies kinase activity by measuring ADP produced during phosphorylation using a luciferase-based system. Radiometric assays involve autoradiography or scintillation counting after incorporation of 32P-labeled ATP into substrate proteins. ELISA-based approaches rely on phospho-specific antibodies to detect activated kinases in cell lysates or purified samples.
-
Western Blot
Western blotting (WB) is a commonly used experimental method in molecular biology, biochemistry, and immunogenetics for identifying and quantifying target proteins. It combines gel electrophoresis with immunoassay, enabling researchers to analyze protein expression, post-translational modifications, and molecular weight.
-
Protocol for Kinase activity and phosphorylation assays
Kinase activity assays measure transfer of phosphate from ATP to a protein or peptide substrate, generating phosphorylated substrate, ADP, or incorporated radiolabeled phosphate as the readout; phosphorylation assays measure site-specific phosphorylation in cells or tissues as a proxy for kinase-pathway activation, inhibition, or substrate regulation. Phosphorylation can be detected by phospho-specific Western blot, immunoprecipitation kinase assay, phospho-immunofluorescence, phospho-flow cytometry, luminescent ADP detection, radiolabeled ATP incorporation, or reporter-based pathway assays, and these readouts can be applied to cancer cells, primary neurons, mouse tumors, organoids, inflammatory macrophages, ferroptosis studies, and mitophagy studies when the kinase target is biologically relevant.
-
Research Protocol for Metabolic Diseases
AMP-activated protein kinase, AMPK, is a conserved cellular energy sensor that responds to reduced cellular energy status and coordinates metabolism by increasing ATP-generating catabolic pathways while suppressing ATP-consuming anabolic processes. In metabolic disease research, the AMPK pathway is experimentally relevant because it regulates hepatic lipid synthesis, fatty acid oxidation, glucose production, skeletal-muscle glucose disposal, mTORC1-linked biosynthesis, autophagy, mitochondrial homeostasis, and whole-body energy balance. The central pathway logic is that energy stress, metformin, exercise-like stimulation, or direct AMPK activators increase AMPKα Thr172 phosphorylation and downstream substrate phosphorylation, including ACC and RAPTOR. Phosphorylation of ACC suppresses lipogenesis and supports fatty acid oxidation, whereas phosphorylation of RAPTOR suppresses mTORC1 signaling and links cellular energy status to growth and protein synthesis control. The pathway is linked
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)